Biora Therapeutics (BIOR) Competitors $0.14 -0.01 (-5.00%) As of 05/20/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock BIOR vs. AWH, SCNI, APVO, GLMD, ELAB, PBM, EVAX, ENTO, TNFA, and PTIXShould you be buying Biora Therapeutics stock or one of its competitors? The main competitors of Biora Therapeutics include Aspira Women's Health (AWH), Scinai Immunotherapeutics (SCNI), Aptevo Therapeutics (APVO), Galmed Pharmaceuticals (GLMD), Elevai Labs (ELAB), Psyence Biomedical (PBM), Evaxion Biotech A/S (EVAX), Entero Therapeutics (ENTO), TNF Pharmaceuticals (TNFA), and Protagenic Therapeutics (PTIX). These companies are all part of the "pharmaceutical products" industry. Biora Therapeutics vs. Aspira Women's Health Scinai Immunotherapeutics Aptevo Therapeutics Galmed Pharmaceuticals Elevai Labs Psyence Biomedical Evaxion Biotech A/S Entero Therapeutics TNF Pharmaceuticals Protagenic Therapeutics Biora Therapeutics (NASDAQ:BIOR) and Aspira Women's Health (NASDAQ:AWH) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, community ranking, analyst recommendations, institutional ownership and risk. Does the MarketBeat Community believe in BIOR or AWH? Aspira Women's Health received 6 more outperform votes than Biora Therapeutics when rated by MarketBeat users. However, 80.00% of users gave Biora Therapeutics an outperform vote while only 16.87% of users gave Aspira Women's Health an outperform vote. CompanyUnderperformOutperformBiora TherapeuticsOutperform Votes880.00% Underperform Votes220.00% Aspira Women's HealthOutperform Votes1416.87%Underperform Votes6983.13% Which has higher valuation and earnings, BIOR or AWH? Aspira Women's Health has higher revenue and earnings than Biora Therapeutics. Aspira Women's Health is trading at a lower price-to-earnings ratio than Biora Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiora Therapeutics$892K0.72-$124.11M-$13.04-0.01Aspira Women's Health$9.18M0.27-$16.69M-$0.98-0.08 Does the media prefer BIOR or AWH? In the previous week, Biora Therapeutics' average media sentiment score of 0.00 equaled Aspira Women's Health'saverage media sentiment score. Company Overall Sentiment Biora Therapeutics Neutral Aspira Women's Health Neutral Do insiders and institutionals believe in BIOR or AWH? 43.7% of Biora Therapeutics shares are held by institutional investors. Comparatively, 12.2% of Aspira Women's Health shares are held by institutional investors. 51.1% of Biora Therapeutics shares are held by insiders. Comparatively, 4.3% of Aspira Women's Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more volatility & risk, BIOR or AWH? Biora Therapeutics has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Comparatively, Aspira Women's Health has a beta of 2.01, suggesting that its share price is 101% more volatile than the S&P 500. Do analysts prefer BIOR or AWH? Biora Therapeutics currently has a consensus price target of $23.00, indicating a potential upside of 16,040.35%. Aspira Women's Health has a consensus price target of $5.50, indicating a potential upside of 6,607.32%. Given Biora Therapeutics' higher probable upside, equities analysts clearly believe Biora Therapeutics is more favorable than Aspira Women's Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biora Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Aspira Women's Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is BIOR or AWH more profitable? Biora Therapeutics has a net margin of 0.00% compared to Aspira Women's Health's net margin of -165.07%. Company Net Margins Return on Equity Return on Assets Biora TherapeuticsN/A N/A -332.47% Aspira Women's Health -165.07%N/A -267.23% SummaryBiora Therapeutics beats Aspira Women's Health on 7 of the 13 factors compared between the two stocks. Get Biora Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIOR vs. The Competition Export to ExcelMetricBiora TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$645,000.00$6.52B$5.37B$8.39BDividend YieldN/A2.65%5.22%4.10%P/E Ratio-0.018.9226.7719.71Price / Sales0.72253.80393.17117.39Price / CashN/A65.8538.2534.62Price / Book0.006.466.794.50Net Income-$124.11M$143.98M$3.23B$248.18M7 Day Performance5.56%2.03%1.53%0.20%1 Month Performance1.79%4.11%10.06%12.37%1 Year Performance-97.93%-2.87%16.74%7.04% Biora Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIORBiora Therapeutics1.7971 of 5 stars$0.14-5.0%$23.00+16,040.4%-98.0%$645,000.00$892,000.00-0.01120Gap UpAWHAspira Women's Health0.9286 of 5 stars$0.08-12.5%$5.50+6,607.3%-97.0%$2.44M$9.18M-0.07110High Trading VolumeSCNIScinai ImmunotherapeuticsN/A$2.54-1.6%N/A-22.4%$2.41M$452,000.00-0.0120APVOAptevo Therapeutics2.1248 of 5 stars$0.34flat$10,952.00+3,221,076.5%-100.0%$2.13M$3.11M0.0050Negative NewsEarnings ReportGLMDGalmed Pharmaceuticals0.4114 of 5 stars$1.28+3.2%N/A-70.7%$2.12MN/A-0.0820Upcoming EarningsGap DownELABElevai Labs0.4914 of 5 stars$2.39+0.4%N/A-99.7%$2.11M$2.45M-0.0418Positive NewsPBMPsyence BiomedicalN/A$3.68-2.4%N/A-99.1%$2.10MN/A0.00N/ANews CoverageEVAXEvaxion Biotech A/S2.1724 of 5 stars$1.49flat$10.00+571.1%-90.3%$2.09M$3.34M-1.0360News CoverageUpcoming EarningsENTOEntero Therapeutics0.7285 of 5 stars$0.42+0.1%N/AN/A$2MN/A0.009Earnings ReportGap DownTNFATNF PharmaceuticalsN/A$0.20+3.2%N/AN/A$1.99MN/A-0.026Earnings ReportHigh Trading VolumePTIXProtagenic Therapeutics1.0348 of 5 stars$3.06-1.6%N/A-72.6%$1.80MN/A-2.412News CoverageGap Up Related Companies and Tools Related Companies Aspira Women's Health Competitors Scinai Immunotherapeutics Competitors Aptevo Therapeutics Competitors Galmed Pharmaceuticals Competitors Elevai Labs Competitors Psyence Biomedical Competitors Evaxion Biotech A/S Competitors Entero Therapeutics Competitors TNF Pharmaceuticals Competitors Protagenic Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BIOR) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biora Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BIOR Stock Free BIOR Stock Alerts